Toll like receptors in liver ischemia reperfusion injury: A novel target for therapeutic modulation?

Expert Opinion on Therapeutic Targets

Volumn 13, Issue 4, 2009, Pages 427-442

  Katsargyris, Athanasios ^a,b   Klonaris, Chris ^b   Alexandrou, Andreas ^b   Giakoustidis, Alexander E ^c   Vasileiou, Ioanna ^a,b   Theocharis, Stamatios ^a  

^a UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

^b UNIVERSITY OF ATHENS   (Greece)

^c ARISTOTLE UNIVERSITY MEDICAL SCHOOL   (Greece)

Author keywords

Agonists; Immune response; Inflammation; Innate immunity; Ligands; Liver ischemia reperfusion injury; TLR signaling; Transgenic mice

Indexed keywords

CD14 ANTIGEN; MYELOID DIFFERENTIATION FACTOR 88; TOLL LIKE RECEPTOR 1; TOLL LIKE RECEPTOR 10; TOLL LIKE RECEPTOR 11; TOLL LIKE RECEPTOR 2; TOLL LIKE RECEPTOR 3; TOLL LIKE RECEPTOR 4; TOLL LIKE RECEPTOR 5; TOLL LIKE RECEPTOR 6; TOLL LIKE RECEPTOR 7; TOLL LIKE RECEPTOR 8; TOLL LIKE RECEPTOR 9; TOLL LIKE RECEPTOR ADAPTOR MOLECULE 1; TOLL LIKE RECEPTOR ADAPTOR MOLECULE 2; ACETYLCYSTEINE; DROSOPHILA PROTEIN; LIGAND; TOLL LIKE RECEPTOR; VESICULAR TRANSPORT ADAPTOR PROTEIN;

ADAPTIVE IMMUNITY; BILE DUCT; CELL POPULATION; DENDRITIC CELL; ENDOTHELIUM CELL; EPITHELIUM CELL; HOMEOSTASIS; HUMAN; INFLAMMATION; INNATE IMMUNITY; KUPFFER CELL; LIVER CELL; LIVER INJURY; LIVER ISCHEMIA; LIVER SINUSOID; NATURAL KILLER CELL; NONHUMAN; PATHOPHYSIOLOGY; PROTEIN EXPRESSION; PROTEIN FUNCTION; REPERFUSION INJURY; REVIEW; SIGNAL TRANSDUCTION; STELLATE CELL; ANIMAL; CLASSIFICATION; COMMUNICABLE DISEASE; DRUG EFFECT; IMMUNOLOGY; ITO CELL; LIVER; LIVER TRANSPLANTATION; MAMMAL; MOUSE; PHYSIOLOGY; VASCULARIZATION;

ACETYLCYSTEINE; ADAPTOR PROTEINS, VESICULAR TRANSPORT; ANIMALS; COMMUNICABLE DISEASES; DENDRITIC CELLS; DROSOPHILA PROTEINS; ENDOTHELIAL CELLS; EPITHELIAL CELLS; HEPATIC STELLATE CELLS; HEPATOCYTES; HUMANS; INFLAMMATION; KUPFFER CELLS; LIGANDS; LIVER; LIVER TRANSPLANTATION; MAMMALS; MICE; MYELOID DIFFERENTIATION FACTOR 88; REPERFUSION INJURY; TOLL-LIKE RECEPTORS;

EID: 67649200262     PISSN: 14728222     EISSN: None     Source Type: Journal    
DOI: 10.1517/14728220902794939     Document Type: Review

References (171)

1. Pasare C, Medzhitov R. Toll-like receptors: linking innate and adaptive immunity. Adv Exp Med Biol 2005;560:11-18 (Pubitemid 43759170)
2. Dunne A, O'Neill LA. Adaptor usage and Toll-like receptor signaling specificity. FEBS Lett 2005;579:3330-3335
3. Janeway CA Jr, Medzhitov R. Innate immune recognition. Annu Rev Immunol 2002;20:197-216 (Pubitemid 34293424)
4. Takeda K, Kaisho T, Akira S. Toll-like receptors. Annu Rev Immunol 2003;21:335-376 (Pubitemid 37174535)
5. Foldes G, von Haehling S, Anker SD. Toll-like receptor modulation in cardiovascular disease: a target for intervention? Expert Opin Investig Drugs 2006;15:857-871
6. Akira S, Uematsu S, Takeuchi O. Pathogen recognition and innate immunity. Cell 2006;124:783-801 (Pubitemid 43261452)
7. Paterson HM, Murphy TJ, Purcell EJ, et al. Injury primes the innate immune system for enhanced Toll-like receptor reactivity. J Immunol 2003;171:1473-1483 (Pubitemid 36900082)
8. Seki E, Tsutsui H, Iimuro Y, et al. Contribution of Toll-like receptor/myeloid differentiation factor 88 signaling to murine liver regeneration. Hepatology 2005;41:443-450 (Pubitemid 40289490)
9. Nagy LE. Recent insights into the role of the innate immune system in the development of alcoholic liver disease. Exp Biol Med (Maywood) 2003;228:882-890 (Pubitemid 37163241)
10. Gregory SH, Wing EJ. Neutrophil-Kupffer cell interaction: a critical component of host defenses to systemic bacterial infections. J Leukoc Biol 2002;72:239-248
11. Decker K. Biologically active products of stimulated liver macrophages Kupffer cells. Eur J Biochem 1990;192:245-261 (Pubitemid 20283490)
12. Rivera CA, Adegboyega P, van Rooijen N, et al. Toll-like receptor-4 signaling and Kupffer cells play pivotal roles in the pathogenesis of non-alcoholic steatohepatitis. J Hepatol 2007;47:571-579 (Pubitemid 47331747)
13. Tsung A, Hoffman RA, Izuishi K, et al. Hepatic ischemia/reperfusion injury involves functional TLR4 signaling in nonparenchymal cells. J Immunol 2005;175:7661-7668 (Pubitemid 41713466)
14. Pasterkamp G, Van Keulen JK, De Kleijn DP. Role of Toll-like receptor 4 in the initiation and progression of atherosclerotic disease. Eur J Clin Invest 2004;34:328-334 (Pubitemid 38748072)
15. Beutler B. Inferences, questions and possibilities in Toll-like receptor signalling. Nature 2004;430:257-263 (Pubitemid 38902439)
16. O'Neill LA. How Toll-like receptors signal: what we know and what we don't know. Curr Opin Immunol 2006;18:3-9 • An up-to-date overview of TLR signaling pathways.
17. Hashimoto C, Hudson KL, Anderson KV. The Toll gene of drosophila, required for dorsal-ventral embryonic polarity, appears to encode a transmembrane protein. Cell 1988;52:269-279
18. Lemaitre B, Nicolas E, Michaut L, et al. The dorsoventral regulatory gene cassette spätzle/Toll/cactus controls the potent antifungal response in drosophila adults. Cell 1996;86:973-983 (Pubitemid 26336801)
19. Divanovic S, Trompette A, Atabani SF, et al. Negative regulation of Toll-like receptor 4 signaling by the Toll-like receptor homolog RP105. Nat Immunol 2005;6:571-578 (Pubitemid 41710727)
20. Ahmad-Nejad P, Hacker H, Rutz M, et al. Bacterial CpG-DNA and lipopolysaccharides activate toll-like receptors at distinct cellular compartments. Eur J Immunol 2002;32:1958-1968 (Pubitemid 34814552)
21. Heil F, Hemmi H, Hochrein H, et al. Species-specific recognition of single-stranded RNA via toll-like receptor 7 and 8. Science 2004;303:1526-1529 (Pubitemid 38314424)
22. Frantz S, Ertl G, Bauersachs J. Mechanisms of disease: Toll-like receptors in cardiovascular disease. Nat Clin Pract Cardiovasc Med 2007;4:444-454 •• An up-to-date review of the role of TLRs in a variety of cardiovascular disorders. (Pubitemid 47180328)
23. Akira S, Takeda K, Kaisho T. Toll-like receptors: critical proteins linking innate and acquired immunity. Nat Immunol 2001;2:675-680 (Pubitemid 32747155)
24. Janssens S, Beyaert R. Role of Toll-like receptors in pathogen recognition. Clin Microbiol Rev 2003;16:637-646 (Pubitemid 37296552)
25. Takeuchi O, Sato S, Horiuchi T, et al. Cutting edge: role of Toll-like receptor 1 in mediating immune response to microbial lipoproteins. J Immunol 2002;169:10-14 (Pubitemid 34686113)
26. Werts C, Tapping RI, Mathison JC, et al. Leptospiral lipopolysaccharide activates cells through a TLR2-dependent mechanism. Nat Immunol 2001;2:346-352 (Pubitemid 33706346)
27. Means TK, Wang S, Lien E, et al. Human toll-like receptors mediate cellular activation by Mycobacterium tuberculosis. J Immunol 1999;163:3920-3927 (Pubitemid 29450920)
28. Shimizu T, Kida Y, Kuwano K. Ureaplasma parvum lipoproteins, including MB antigen, activate NF-κB through TLR1, TLR2 and TLR6. Microbiology 2008;154:1318-1325
29. Henneke P, Dramsi S, Mancuso G, et al. Lipoproteins are critical TLR2 activating toxins in group B streptococcal sepsis. J Immunol 2008;180:6149-6158
30. Schwandner R, Dziarski R, Wesche H, et al. Peptidoglycan- and lipoteichoic acid-induced cell activation is mediated by toll-like receptor 2. J Biol Chem 1999;274:17406-17409 (Pubitemid 129519082)
31. Knapp S, von Aulock S, Leendertse M, et al. Lipoteichoic acid-induced lung inflammation depends on TLR2 and the concerted action of TLR4 and the platelet-activating factor receptor. J Immunol 2008;180:3478-3484
32. Ozinsky A, Underhill DM, Fontenot JD, et al. The repertoire for pattern recognition of pathogens by the innate immune system is defined by cooperation between toll-like receptors. Proc Natl Acad Sci USA 2000;97:13766-13771
33. Zahringer U, Lindner B, Inamura S, et al. TLR2 - promiscuous or specific? A critical re-evaluation of a receptor expressing apparent broad specificity. Immunobiology 2008;213:205-224
34. Hajjar AM, O'Mahony DS, Ozinsky A, et al. Cutting edge: functional interactions between toll-like receptor (TLR) 2 and TLR1 or TLR6 in response to phenol-soluble modulin. J Immunol 2001;166:15-19 (Pubitemid 32038411)
35. Ray A, Biswas T. Porin of shigella dysenteriae enhances Toll-like receptors 2 and 6 of mouse peritoneal B-2 cells and induces the expression of immunoglobulin M, immunoglobulin G2a and immunoglobulin A. Immunology 2005;114:94-100 (Pubitemid 40030297)
36. Burke JM, Ganley-Leal LM, Khatri A, Wetzler LM. Neisseria meningitidis PorB, a TLR2 ligand, induces an antigen-specific eosinophil recall response: potential adjuvant for helminth vaccines? J Immunol 2007;179:3222-3230
37. Bieback K, Lien E, Klagge IM, et al. Hemagglutinin protein of wild-type measles virus activates toll-like receptor 2 signaling. J Virol 2002;76:8729-8736 (Pubitemid 34864068)
38. Zhao Y, Yokota K, Ayada K, et al. Helicobacter pylori heat-shock protein 60 induces interleukin-8 via a Toll-like receptor (TLR)2 and mitogen-activated protein (MAP) kinase pathway in human monocytes. J Med Microbiol 2007;56:154-164 (Pubitemid 46302716)
39. Li M, Carpio DF, Zheng Y, et al. An essential role of the NF-κB/Toll-like receptor pathway in induction of inflammatory and tissue-repair gene expression by necrotic cells. J Immunol 2001;166:7128-7135 (Pubitemid 32525583)
40. Poltorak A, He X, Smirnova I, et al. Defective LPS signaling in C3H/HeJ and C57BL/10ScCr mice: mutations in Tlr4 gene. Science 1998;282:2085-2088 (Pubitemid 29001265)
41. Hoshino K, Kaisho T, Iwabe T, et al. Differential involvement of IFN-β in Toll-like receptor-stimulated dendritic cell activation. Int Immunol 2002;14:1225-1231 (Pubitemid 35175229)
42. Qureshi ST, Lariviere L, Leveque G, et al. Endotoxin-tolerant mice have mutations in Toll-like receptor 4 (Tlr4). J Exp Med 1999;189:615-625 (Pubitemid 29193362)
43. Necela BM, Su W, Thompson EA. Toll-like receptor 4 mediates cross-talk between peroxisome proliferator-activated receptor γ and nuclear factor-κB in macrophages. Immunology 2008;125:344-358
44. Takeuchi O, Hoshino K, Kawai T, et al. Differential roles of TLR2 and TLR4 in recognition of Gram-negative and Gram-positive bacterial cell wall components. Immunity 1999;11:443-451 • A basic paper describing the immune role of TLR-2 and-4. (Pubitemid 29504199)
45. Dessing MC, Schouten M, Draing C, et al. Role played by Toll-like receptors 2 and 4 in lipoteichoic acid-induced lung inflammation and coagulation. J Infect Dis 2008;197:245-252 (Pubitemid 351263443)
46. Seo HS, Michalek SM, Nahm MH. Lipoteichoic acid is important in innate immune responses to Gram-positive bacteria. Infect Immun 2008;76:206-213
47. Kawasaki K, Akashi S, Shimazu R, et al. Mouse toll-like receptor 4.MD-2 complex mediates lipopolysaccharide-mimetic signal transduction by taxol. J Biol Chem 2000;275:2251-2254 (Pubitemid 30081977)
48. Beg AA. Endogenous ligands of Toll-like receptors: implications for regulating inflammatory and immune responses. Trends Immunol 2002;23:509-512 (Pubitemid 35223541)
49. Zou N, Ao L, Cleveland JC Jr, et al. Critical role of extracellular heat shock cognate protein 70 in the myocardial inflammatory response and cardiac dysfunction after global ischemia-reperfusion. Am J Physiol Heart Circ Physiol 2008;294:H2805-13
50. Lehnardt S, Schott E, Trimbuch T, et al. A vicious cycle involving release of heat shock protein 60 from injured cells and activation of toll-like receptor 4 mediates neurodegeneration in the CNS. J Neurosci 2008;28:2320-2331 (Pubitemid 351348178)
51. Kurt-Jones EA, Popova L, Kwinn L, et al. Pattern recognition receptors TLR4 and CD14 mediate response to respiratory syncytial virus. Nat Immunol 2000;1:398-401
52. Awomoyi AA, Rallabhandi P, Pollin TI, et al. Association of TLR4 polymorphisms with symptomatic respiratory syncytial virus infection in high-risk infants and young children. J Immunol 2007;179:3171-3177
53. Termeer C, Benedix F, Sleeman J, et al. Oligosaccharides of hyaluronan activate dendritic cells via toll-like receptor 4. J Exp Med 2002;195:99-111 (Pubitemid 34074500)
54. Kuhns DB, Priel DA, Gallin JI. Induction of human monocyte interleukin (IL)-8 by fibrinogen through the toll-like receptor pathway. Inflammation 2007;30:178-188 (Pubitemid 47573147)
55. Schoneveld AH, Hoefer I, Sluijter JP, et al. Atherosclerotic lesion development and Toll like receptor 2 and 4 responsiveness. Atherosclerosis 2008;197:95-104 (Pubitemid 351273277)
56. Gondokaryono SP, Ushio H, Niyonsaba F, et al. The extra domain A of fibronectin stimulates murine mast cells via toll-like receptor 4. J Leukoc Biol 2007;82:657-665 (Pubitemid 47367158)
57. Smith MF Jr, Novotny J, Carl VS, Comeau LD. Helicobacter pylori and toll-like receptor agonists induce syndecan-4 expression in an NF-κB-dependent manner. Glycobiology 2006;16:221-229 (Pubitemid 43264688)
58. Miller YI, Viriyakosol S, Binder CJ, et al. Minimally modified LDL binds to CD14, induces macrophage spreading via TLR4/MD-2, and inhibits phagocytosis of apoptotic cells. J Biol Chem 2003;278:1561-1568 (Pubitemid 36801384)
59. Biragyn A, Ruffini PA, Leifer CA, et al. Toll-like receptor 4-dependent activation of dendritic cells by β-defensin 2. Science 2002;298:1025-1029 (Pubitemid 35247310)
60. Sheng KC, Pouniotis DS, Wright MD, et al. Mannan derivatives induce phenotypic and functional maturation of mouse dendritic cells. Immunology 2006;118:372-383 (Pubitemid 43911650)
61. Hemmi H, Takeuchi O, Kawai T, et al. A Toll-like receptor recognizes bacterial DNA. Nature 2000;408:740-745 (Pubitemid 32015992)
62. Dan JM, Wang JP, Lee CK, Levitz SM. Cooperative stimulation of dendritic cells by Cryptococcus neoformans mannoproteins and CpG oligodeoxynucleotides. PLoS ONE 2008;3:e2046. Published online April 30, 2008, doi:10.1371/journal. pone.0002046. (Pubitemid 352024773)
63. Haas T, Metzger J, Schmitz F, et al. The DNA sugar backbone 2′ deoxyribose determines toll-like receptor 9 activation. Immunity 2008;28:315-323 (Pubitemid 351335308)
64. Coban C, Ishii KJ, Kawai T, et al. Toll-like receptor 9 mediates innate immune activation by the malaria pigment hemozoin. J Exp Med 2005;201:19-25 (Pubitemid 40130079)
65. Parroche P, Lauw FN, Goutagny N, et al. Malaria hemozoin is immunologically inert but radically enhances innate responses by presenting malaria DNA to Toll-like receptor 9. Proc Natl Acad Sci USA 2007;104:1919-1924 (Pubitemid 46239879)
66. Leadbetter EA, Rifkin IR, Hohlbaum AM, et al. Chromatin-IgG complexes activate B cells by dual engagement of IgM and Toll-like receptors. Nature 2002;416:603-607 (Pubitemid 34406754)
67. Alexopoulou L, Holt AC, Medzhitov R, Flavell RA. Recognition of double-stranded RNA and activation of NF-κB by Toll-like receptor 3. Nature 2001;413:732-738 (Pubitemid 33009951)
68. Liu L, Botos I, Wang Y, et al. Structural basis of toll-like receptor 3 signaling with double-stranded RNA. Science 2008;320:379-381 (Pubitemid 351555661)
69. Forsbach A, Nemorin JG, Montino C, et al. Identification of RNA sequence motifs stimulating sequence-specific TLR8-dependent immune responses. J Immunol 2008;180:3729-3738
70. Hattermann K, Picard S, Borgeat M, et al. The Toll-like receptor 7/8-ligand resiquimod (R-848) primes human neutrophils for leukotriene B4, prostaglandin E2 and platelet-activating factor biosynthesis. FASEB J 2007;21:1575-1585 (Pubitemid 46684859)
71. Diebold SS. Recognition of viral single-stranded RNA by Toll-like receptors. Adv Drug Deliv Rev 2008;60:813-823
72. Gantier MP, Tong S, Behlke MA, et al. Tlr7 is involved in sequence-specific sensing of single-stranded RNAs in human macrophages. J Immunol 2008;180:2117-2124
73. Hayashi F, Smith KD, Ozinsky A, et al. The innate immune response to bacterial flagellin is mediated by Toll-like receptor 5. Nature 2001;410:1099-1103 (Pubitemid 32391041)
74. Galkin VE, Yu X, Bielnicki J, et al. Divergence of quaternary structures among bacterial flagellar filaments. Science 2008;320:382-385 (Pubitemid 351555662)
75. Palazzo M, Gariboldi S, Zanobbio L, et al. Cross-talk among Toll-like receptors and their ligands. Int Immunol 2008;20:709-718 (Pubitemid 351619238)
76. Zhang D, Zhang G, Hayden MS, et al. A toll-like receptor that prevents infection by uropathogenic bacteria. Science 2004;303:1522-1526 (Pubitemid 38314423)
77. Plattner F, Yarovinsky F, Romero S, et al. Toxoplasma profilin is essential for host cell invasion and TLR11-dependent induction of an interleukin-12 response. Cell Host Microbe 2008;3:77-87 (Pubitemid 351201784)
78. Vabulas RM, Ahmad-Nejad P, da Costa C, et al. Endocytosed HSP60s use toll-like receptor 2 (TLR2) and TLR4 to activate the toll/interleukin-1 receptor signaling pathway in innate immune cells. J Biol Chem 2001;276:31332-31339 (Pubitemid 37385004)
79. Smiley ST, King JA, Hancock WW. Fibrinogen stimulates macrophage chemokine secretion through toll-like receptor 4. J Immunol 2001;167:2887-2894 (Pubitemid 32768923)
80. Heine H, Lien E. Toll-like receptors and their function in innate and adaptive immunity. Int Arch Allergy Immunol 2003;130:180-192 (Pubitemid 36362002)
81. Chen CJ, Kono H, Golenbock D, et al. Identification of a key pathway required for the sterile inflammatory response triggered by dying cells. Nat Med 2007;13:851-856 (Pubitemid 47038190)
82. Okamura Y, Watari M, Jerud ES, et al. The extra domain A of fibronectin activates Toll-like receptor 4. J Biol Chem 2001;276:10229-10233 (Pubitemid 33649249)
83. Scheibner KA, Lutz MA, Boodoo S, et al. Hyaluronan fragments act as an endogenous danger signal by engaging TLR2. J Immunol 2006;177:1272-1281 (Pubitemid 44036633)
84. Frantz S, Kelly RA, Bourcier T. Role of TLR-2 in the activation of nuclear factor κB by oxidative stress in cardiac myocytes. J Biol Chem 2001;276:5197-5203 (Pubitemid 37371416)
85. Johnson GB, Brunn GJ, Tang AH, Platt JL. Evolutionary clues to the functions of the Toll-like family as surveillance receptors. Trends Immunol 2003;24:19-24 (Pubitemid 35462109)
86. Matzinger P. The danger model: a renewed sense of self. Science 2002;296:301-305 (Pubitemid 34303674)
87. Shi Y, Evans JE, Rock KL. Molecular identification of a danger signal that alerts the immune system to dying cells. Nature 2003;425:516-521 (Pubitemid 37237047)
88. Zhai Y, Shen XD, O'Connell R, et al. Cutting edge: TLR4 activation mediates liver ischemia/reperfusion inflammatory response via IFN regulatory factor 3-dependent MyD88-independent pathway. J Immunol 2004;173:7115-7119 •• A key paper reporting TLR involvement in liver IRI. (Pubitemid 39628144)
89. Kaisho T, Akira S. Toll-like receptor function and signaling. J Allergy Clin Immunol 2006;117:979-87; quiz 988
90. Medzhitov R, Preston-Hurlburt P, Kopp E, et al. MyD88 is an adaptor protein in the hToll/IL-1 receptor family signaling pathways. Mol Cell 1998;2:253-258 (Pubitemid 128373651)
91. Frantz S, Kobzik L, Kim YD, et al. Toll4 (TLR4) expression in cardiac myocytes in normal and failing myocardium. J Clin Invest 1999;104:271-280
92. Cook DN, Pisetsky DS, Schwartz DA. Toll-like receptors in the pathogenesis of human disease. Nat Immunol 2004;5:975-979 (Pubitemid 41057713)
93. Akira S. Toll-like receptor signaling. J Biol Chem 2003;278:38105-38108 (Pubitemid 37221695)
94. Sasu S, LaVerda D, Qureshi N, et al. Chlamydia pneumoniae and chlamydial heat shock protein 60 stimulate proliferation of human vascular smooth muscle cells via toll-like receptor 4 and p44/p42 mitogen-activated protein kinase activation. Circ Res 2001;89:244-250 (Pubitemid 34132682)
95. Yamamoto M, Sato S, Hemmi H, et al. TRAM is specifically involved in the Toll-like receptor 4-mediated MyD88-independent signaling pathway. Nat Immunol 2003;4:1144-1150 (Pubitemid 37428043)
96. Bin LH, Xu LG, Shu HB. TIRP, a novel Toll/interleukin-1 receptor (TIR) domain-containing adapter protein involved in TIR signaling. J Biol Chem 2003;278:24526-24532 (Pubitemid 37548605)
97. Harari OA, Alcaide P, Ahl D, et al. Absence of TRAM restricts Toll-like receptor 4 signaling in vascular endothelial cells to the MyD88 pathway. Circ Res 2006;98:1134-1140 (Pubitemid 43948099)
98. Liew FY, Xu D, Brint EK, O'Neill LA. Negative regulation of toll-like receptor-mediated immune responses. Nat Rev Immunol 2005;5:446-458
99. Sabroe I, Parker LC, Dower SK, Whyte MK. The role of TLR activation in inflammation. J Pathol 2008;214:126-135 (Pubitemid 351160151)
100. Wald D, Qin J, Zhao Z, et al. SIGIRR, a negative regulator of Toll-like receptor-interleukin 1 receptor signaling. Nat Immunol 2003;4:920-927 (Pubitemid 37098664)
101. Brint EK, Xu D, Liu H, et al. ST2 is an inhibitor of interleukin 1 receptor and Toll-like receptor 4 signaling and maintains endotoxin tolerance. Nat Immunol 2004;5:373-379 (Pubitemid 38500085)
102. Mansell A, Smith R, Doyle SL, et al. Suppressor of cytokine signaling 1 negatively regulates Toll-like receptor signaling by mediating mal degradation. Nat Immunol 2006;7:148-155 (Pubitemid 43135880)
103. Carty M, Goodbody R, Schroder M, et al. The human adaptor SARM negatively regulates adaptor protein TRIF-dependent Toll-like receptor signaling. Nat Immunol 2006;7:1074-1081 (Pubitemid 44420652)
104. Kobayashi K, Hernandez LD, Galan JE, et al. IRAK-M is a negative regulator of Toll-like receptor signaling. Cell 2002;110:191-202 (Pubitemid 34876547)
105. Nakagawa R, Naka T, Tsutsui H, et al. SOCS-1 participates in negative regulation of LPS responses. Immunity 2002;17:677-687 (Pubitemid 35351512)
106. Medvedev AE, Sabroe I, Hasday JD, Vogel SN. Tolerance to microbial TLR ligands: molecular mechanisms and relevance to disease. J Endotoxin Res 2006;12:133-150 (Pubitemid 47487520)
107. Cario E, Golenbock DT, Visintin A, et al. Trypsin-sensitive modulation of intestinal epithelial MD-2 as mechanism of lipopolysaccharide tolerance. J Immunol 2006;176:4258-4266 (Pubitemid 44264405)
108. Parker LC, Jones EC, Prince LR, et al. Endotoxin tolerance induces selective alterations in neutrophil function. J Leukoc Biol 2005;78:1301-1305 (Pubitemid 41779236)
109. Medvedev AE, Henneke P, Schromm A, et al. Induction of tolerance to lipopolysaccharide and mycobacterial components in chinese hamster ovary/CD14 cells is not affected by overexpression of toll-like receptors 2 or 4. J Immunol 2001;167:2257-2267 (Pubitemid 32747538)
110. Medvedev AE, Piao W, Shoenfelt J, et al. Role of TLR4 tyrosine phosphorylation in signal transduction and endotoxin tolerance. J Biol Chem 2007;282:16042-16053 (Pubitemid 47100380)
111. Negishi H, Ohba Y, Yanai H, et al. Negative regulation of Toll-like-receptor signaling by IRF-4. Proc Natl Acad Sci USA 2005;102:15989-15994 (Pubitemid 41552855)
112. Carmody RJ, Ruan Q, Palmer S, et al. Negative regulation of toll-like receptor signaling by NF-κB p50 ubiquitination blockade. Science 2007;317:675-678 (Pubitemid 47229968)
113. Hu X, Chen J, Wang L, Ivashkiv LB. Crosstalk among Jak-STAT, Toll-like receptor, and ITAM-dependent pathways in macrophage activation. J Leukoc Biol 2007;82:237-243 (Pubitemid 47230632)
114. Hamerman JA, Jarjoura JR, Humphrey MB, et al. Cutting edge: inhibition of TLR and FcR responses in macrophages by triggering receptor expressed on myeloid cells (TREM)-2 and DAP12. J Immunol 2006;177:2051-2055 (Pubitemid 44200961)
115. Strassheim D, Kim JY, Park JS, et al. Involvement of SHIP in TLR2-induced neutrophil activation and acute lung injury. J Immunol 2005;174:8064-8071 (Pubitemid 40806317)
116. Fang H, Pengal RA, Cao X, et al. Lipopolysaccharide-induced macrophage inflammatory response is regulated by SHIP. J Immunol 2004;173:360-366 (Pubitemid 38797361)
117. Seki E, Brenner DA. Toll-like receptors and adaptor molecules in liver disease: update. Hepatology 2008;48:322-335 (Pubitemid 351975556)
118. Schwabe RF, Seki E, Brenner DA. Toll-like receptor signaling in the liver. Gastroenterology 2006;130:1886-1900 (Pubitemid 43668871)
119. Su GL, Klein RD, Aminlari A, et al. Kupffer cell activation by lipopolysaccharide in rats: role for lipopolysaccharide binding protein and toll-like receptor 4. Hepatology 2000;31:932-936 (Pubitemid 30169941)
120. Fox ES, Thomas P, Broitman SA. Clearance of gut-derived endotoxins by the liver. Release and modification of 3H 14C-lipopolysaccharide by isolated rat Kupffer cells. Gastroenterology 1989;96:456-461
121. Van Bossuyt H, De Zanger RB, Wisse E. Cellular and subcellular distribution of injected lipopolysaccharide in rat liver and its inactivation by bile salts. J Hepatol 1988;7:325-337 (Pubitemid 19000522)
122. Seki E, Tsutsui H, Nakano H, et al. Lipopolysaccharide-induced IL-18 secretion from murine Kupffer cells independently of myeloid differentiation factor 88 that is critically involved in induction of production of IL-12 and IL-1β. J Immunol 2001;166:2651-2657 (Pubitemid 32173504)
123. Seki E, Tsutsui H, Tsuji NM, et al. Critical roles of myeloid differentiation factor 88-dependent proinflammatory cytokine release in early phase clearance of listeria monocytogenes in mice. J Immunol 2002;169:3863-3868
124. Tsutsui H, Matsui K, Okamura H, Nakanishi K. Pathophysiological roles of interleukin-18 in inflammatory liver diseases. Immunol Rev 2000;174:192-209 (Pubitemid 30201389)
125. Thobe BM, Frink M, Hildebrand F, et al. The role of MAPK in Kupffer cell toll-like receptor (TLR) 2-, TLR4-, and TLR9-mediated signaling following trauma-hemorrhage. J Cell Physiol 2007;210:667-675 (Pubitemid 46185036)
126. Wu J, Lu M, Meng Z, et al. Toll-like receptor-mediated control of HBV replication by nonparenchymal liver cells in mice. Hepatology 2007;46:1769-1778
127. Schuchmann M, Hermann F, Herkel J, et al. HSP60 and CpG-DNA- oligonucleotides differentially regulate LPS-tolerance of hepatic Kupffer cells. Immunol Lett 2004;93:199-204 (Pubitemid 38670374)
128. Lichtman SN, Wang J, Lemasters JJ. LPS receptor CD14 participates in release of TNF-α in RAW 264.7 and peritoneal cells but not in Kupffer cells. Am J Physiol 1998;275:G39-46 (Pubitemid 128731413)
129. Knolle P, Schlaak J, Uhrig A, et al. Human Kupffer cells secrete IL-10 in response to lipopolysaccharide (LPS) challenge. J Hepatol 1995;22:226-229
130. Matsumura T, Degawa T, Takii T, et al. TRAF6-NF-κB pathway is essential for interleukin-1-induced TLR2 expression and its functional response to TLR2 ligand in murine hepatocytes. Immunology 2003;109:127-136 (Pubitemid 36577983)
131. Matsumura T, Ito A, Takii T, et al. Endotoxin and cytokine regulation of Toll-like receptor (TLR) 2 and TLR4 gene expression in murine liver and hepatocytes. J Interferon Cytokine Res 2000;20:915-921 (Pubitemid 30776693)
132. Li K, Chen Z, Kato N, et al. Distinct poly(I-C) and virus-activated signaling pathways leading to interferon-β production in hepatocytes. J Biol Chem 2005;280:16739-16747 (Pubitemid 41389131)
133. Liu S, Gallo DJ, Green AM, et al. Role of toll-like receptors in changes in gene expression and NF-κB activation in mouse hepatocytes stimulated with lipopolysaccharide. Infect Immun 2002;70:3433-3442 (Pubitemid 34665980)
134. Isogawa M, Robek MD, Furuichi Y, Chisari FV. Toll-like receptor signaling inhibits hepatitis B virus replication in vivo. J Virol 2005;79:7269-7272 (Pubitemid 40677357)
135. Seki E, De Minicis S, Osterreicher CH, et al. TLR4 enhances TGF-β signaling and hepatic fibrosis. Nat Med 2007;13:1324-1332 (Pubitemid 350073596)
136. Mimura Y, Sakisaka S, Harada M, et al. Role of hepatocytes in direct clearance of lipopolysaccharide in rats. Gastroenterology 1995;109:1969-1976
137. Hampton RY, Golenbock DT, Penman M, et al. Recognition and plasma clearance of endotoxin by scavenger receptors. Nature 1991;352:342-344 (Pubitemid 21912355)
138. Vishnyakova TG, Bocharov AV, Baranova IN, et al. Binding and internalization of lipopolysaccharide by Cla-1, a human orthologue of rodent scavenger receptor B1. J Biol Chem 2003;278:22771-22780 (Pubitemid 36830338)
139. Bataller R, Brenner DA. Liver fibrosis. J Clin Invest 2005;115:209-218 (Pubitemid 40385459)
140. Paik YH, Schwabe RF, Bataller R, et al. Toll-like receptor 4 mediates inflammatory signaling by bacterial lipopolysaccharide in human hepatic stellate cells. Hepatology 2003;37:1043-1055 (Pubitemid 36538681)
141. Watanabe A, Hashmi A, Gomes DA, et al. Apoptotic hepatocyte DNA inhibits hepatic stellate cell chemotaxis via toll-like receptor 9. Hepatology 2007;46:1509-1518 (Pubitemid 350155533)
142. Brun P, Castagliuolo I, Pinzani M, et al. Exposure to bacterial cell wall products triggers an inflammatory phenotype in hepatic stellate cells. Am J Physiol Gastrointest Liver Physiol 2005;289:G571-8 (Pubitemid 41216395)
143. Harada K, Ohira S, Isse K, et al. Lipopolysaccharide activates nuclear factor-kappaB through Toll-like receptors and related molecules in cultured biliary epithelial cells. Lab Invest 2003;83:1657-1667 (Pubitemid 37421106)
144. Chen XM, O'Hara SP, Nelson JB, et al. Multiple TLRs are expressed in human cholangiocytes and mediate host epithelial defense responses to Cryptosporidium parvum via activation of NF-κB. J Immunol 2005;175:7447-7456 (Pubitemid 41713442)
145. Harada K, Isse K, Nakanuma Y. Interferon γ accelerates NF-?B activation of biliary epithelial cells induced by Toll-like receptor and ligand interaction. J Clin Pathol 2006;59:184-190 (Pubitemid 43235585)
146. Harada K, Isse K, Sato Y, et al. Endotoxin tolerance in human intrahepatic biliary epithelial cells is induced by upregulation of IRAK-M. Liver Int 2006;26:935-942 (Pubitemid 44323411)
147. Uhrig A, Banafsche R, Kremer M, et al. Development and functional consequences of LPS tolerance in sinusoidal endothelial cells of the liver. J Leukoc Biol 2005;77:626-633 (Pubitemid 40628742)
148. Sarphie TG, D'Souza NB, Deaciuc IV. Kupffer cell inactivation prevents lipopolysaccharide-induced structural changes in the rat liver sinusoid: an electron-microscopic study. Hepatology 1996;23:788-796 (Pubitemid 26111993)
149. Asselin-Paturel C, Brizard G, Chemin K, et al. Type I interferon dependence of plasmacytoid dendritic cell activation and migration. J Exp Med 2005;201:1157-1167 (Pubitemid 40528442)
150. Shu SA, Lian ZX, Chuang YH, et al. The role of CD11c+ hepatic dendritic cells in the induction of innate immune responses. Clin Exp Immunol 2007;149:335-343 (Pubitemid 47063054)
151. De Creus A, Abe M, Lau AH, et al. Low TLR4 expression by liver dendritic cells correlates with reduced capacity to activate allogeneic T cells in response to endotoxin. J Immunol 2005;174:2037-2045 (Pubitemid 40223946)
152. Sawaki J, Tsutsui H, Hayashi N, et al. Type 1 cytokine/chemokine production by mouse NK cells following activation of their TLR/MyD88-mediated pathways. Int Immunol 2007;19:311-320 (Pubitemid 46344696)
153. Meyer-Bahlburg A, Khim S, Rawlings DJ. B cell intrinsic TLR signals amplify but are not required for humoral immunity. J Exp Med 2007;204:3095-3101
154. Salio M, Speak AO, Shepherd D, et al. Modulation of human natural killer T cell ligands on TLR-mediated antigen-presenting cell activation. Proc Natl Acad Sci USA 2007;104:20490-20495
155. Kupiec-Weglinski JW, Busuttil RW. Ischemia and reperfusion injury in liver transplantation. Transplant Proc 2005;37:1653-1656 (Pubitemid 40790787)
156. Laskowski I, Pratschke J, Wilhelm MJ, et al. Molecular and cellular events associated with ischemia/reperfusion injury. Ann Transplant 2000;5:29-35
157. Fondevila C, Busuttil RW, Kupiec-Weglinski JW. Hepatic ischemia/reperfusion injury-a fresh look. Exp Mol Pathol 2003;74:86-93 (Pubitemid 36438656)
158. Wang L, Xu JB, Wu HS, et al. The relationship between activation of TLR4 and partial hepatic ischemia/reperfusion injury in mice. Hepatobiliary Pancreat Dis Int 2006;5:101-104 (Pubitemid 43298712)
159. Tsung A, Klune JR, Zhang X, et al. HMGB1 release induced by liver ischemia involves Toll-like receptor 4 dependent reactive oxygen species production and calcium-mediated signaling. J Exp Med 2007;204:2913-2923 (Pubitemid 350179560)
160. Zhai Y, Shen XD, Gao F, et al. CXCL10 regulates liver innate immune response against ischemia and reperfusion injury. Hepatology 2008;47:207-214 • An important paper on the role of CXCL10. (Pubitemid 351171058)
161. Tsung A, Zheng N, Jeyabalan G, et al. Increasing numbers of hepatic dendritic cells promote HMGB1-mediated ischemia-reperfusion injury. J Leukoc Biol 2007;81:119-128 (Pubitemid 46021260)
162. Shen XD, Ke B, Zhai Y, et al. Absence of toll-like receptor 4 (TLR4) signaling in the donor organ reduces ischemia and reperfusion injury in a murine liver transplantation model. Liver Transpl 2007;13:1435-1443 (Pubitemid 47629578)
163. John B, Klein I, Crispe IN. Immune role of hepatic TLR-4 revealed by orthotopic mouse liver transplantation. Hepatology 2007;45:178-186 (Pubitemid 46144377)
164. Prince JM, Levy RM, Yang R, et al. Toll-like receptor-4 signaling mediates hepatic injury and systemic inflammation in hemorrhagic shock. J Am Coll Surg 2006;202:407-417 (Pubitemid 43356214)
165. Frink M, Hsieh YC, Thobe BM, et al. TLR4 regulates Kupffer cell chemokine production, systemic inflammation and lung neutrophil infiltration following trauma-hemorrhage. Mol Immunol 2007;44:2625-2630 (Pubitemid 46240323)
166. Hsieh YC, Frink M, Hsieh CH, et al. Downregulation of migration inhibitory factor is critical for estrogen-mediated attenuation of lung tissue damage following trauma-hemorrhage. Am J Physiol Lung Cell Mol Physiol 2007;292:L1227-32 (Pubitemid 47084867)
167. Zhang JX, Wu HS, Wang H, et al. Protection against hepatic ischemia/reperfusion injury via downregulation of toll-like receptor 2 expression by inhibition of Kupffer cell function. World J Gastroenterol 2005;11:4423-4426 (Pubitemid 41093966)
168. Zhai Y, Qiao B, Shen XD, et al. Evidence for the pivotal role of endogenous toll-like receptor 4 ligands in liver ischemia and reperfusion injury. Transplantation 2008;85:1016-1022 (Pubitemid 351543166)
169. Wang H, Li ZY, Wu HS, et al. Endogenous danger signals trigger hepatic ischemia/reperfusion injury through toll-like receptor 4/nuclear factor-kappa b pathway. Chin Med J (Engl) 2007;120:509-514 (Pubitemid 46510764)
170. Jin X, Wang L, Wu HS, et al. N-acetylcysteine inhibits activation of toll-like receptor 2 and 4 gene expression in the liver and lung after partial hepatic ischemia-reperfusion injury in mice. Hepatobiliary Pancreat Dis Int 2007;6:284-289 (Pubitemid 46925250)
171. Ke B, Shen XD, Tsuchihashi S, et al. Viral interleukin-10 gene transfer prevents liver ischemia-reperfusion injury: Toll-like receptor-4 and heme oxygenase-1 signaling in innate and adaptive immunity. Hum Gene Ther 2007;18:355-366 • An important paper reporting attempts for TLR4 therapeutic modulation in liver IRI. (Pubitemid 46709347)